VENUS REMEDIES LTD.

NSE : VENUSREMBSE : 526953ISIN CODE : INE411B01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE327.05-7.65 (-2.29 %)
PREV CLOSE ( ) 334.70
OPEN PRICE ( ) 345.00
BID PRICE (QTY) 325.00 (1)
OFFER PRICE (QTY) 326.55 (10)
VOLUME 1928
TODAY'S LOW / HIGH ( )324.00 345.00
52 WK LOW / HIGH ( )185.65 429.6
NSE328.70-6.5 (-1.94 %)
PREV CLOSE( ) 335.20
OPEN PRICE ( ) 332.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 38600
TODAY'S LOW / HIGH( ) 323.05 342.95
52 WK LOW / HIGH ( )188.6 430
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax379.30364.08251.117.77-207.65
Adjustment233.31263.32218.92415.65607.24
Changes In working Capital-246.34-216.38613.91208.2353.68
Cash Flow after changes in Working Capital366.27411.021083.95631.64453.27
Cash Flow from Operating Activities366.27411.021318.37776.04453.27
Cash Flow from Investing Activities-508.30-167.27564.94-47.48-113.32
Cash Flow from Financing Activities-5.68-94.77-1622.43-730.02-351.67
Net Cash Inflow / Outflow-147.70148.98260.88-1.46-11.72
Opening Cash & Cash Equivalents432.56288.7919.4220.3339.83
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations-72.74-5.218.490.56NA
Closing Cash & Cash Equivalent212.12432.56288.7919.4228.10

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.